The LP with the most FG Inventory in Canada. That is a pretty trend line
This will get updated after next Monday's earnings release. But it might give you an idea of what s possible for the upcoming report, As Aphria doesn't break down WIP and FG, as such I have used an Inventory Delta. Q0 = November 2018 Q0-1 = August 2018 was the Q where they destroyed plants as they did not have the staff to harvest.. Q0-2 = May 2018... And in March 2018 Phase III was licensed Q0-3= Feb 2018
Q0 ended Dec 31, 2018 and saw a large reduction in Finished Goods Inventory available to start Q, which just ended March 31, 2019. I am very interested to see what progress was made towards the +EBITDA for Q to end June 30/19. Q0-1 ended Sept 30, 2018 and included acquisition of Medreleaf [July/2018] Q0-2 ended June 30, 2018 and included acquisition of CMED [May/2018]
Our next patent is a cannabis extraction protocol and system developed by Nextleaf Solutions. The patent has recently been granted in the USA under US9987567B1. Nextleaf’s CEO has touted this patent as an accomplishment for ‘beating big pharma, big tobacco, big alcohol and every single billions-dollar cannabis company to the first issued patent for extraction and purification of cannabinoids’. We’ll be evaluating the relevance of this statement along with the patent. Starting with the abstract:“Raw plant material is mixed with ethanol under pressure to extract essential elements. The resulting crude oil and ethanol with the dissolved essential elements is separated from the raw plant…
I am going to be in transit for Friday-Tuesday, so I thought I would leave this for you. Q0-3 = Q4 F2018 where CGC wrote down $20 million in Inventory. Q0-1 is Q2F19 where CGC wrote down $16 million in Bio Assets Q0 = Most recent Q Q3 where CGC wrote down $14-15 million in Bio Assets and +$41 million in Merchandise & Supplies Inventory are on B/S.